New York: The South African variant of Covid-19 may significantly reduce antibody protection from the Pfizer-BioNTech vaccine, as per a laboratory study, the pharmaceutical companies said. However, human trials are still to be conducted in this regard. According to the study, published in The New England Journal of Medicine, although the results indicated a reduction […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.